A Phase 1/2 Study of SHP648, an Adeno-Associated Viral Vector for Gene Transfer in Hemophilia B Subjects

NCT04394286 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
2
Enrollment
INDUSTRY
Sponsor class

Stopped Takeda has decided to not further develop the SHP648 (TAK-748) program. No subjects have been dosed with SHP648. The decision to terminate study SHP648-101 is not due to any safety concerns.

Conditions

Interventions

Sponsor

Baxalta now part of Shire